triazoles has been researched along with inosine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, TE; Spector, T | 1 |
| Bauer, RJ; Khare, GP; Robins, RK; Sidwell, RW; Simon, LN; Streeter, DG; Witkowski, JT | 1 |
| Bremer, HC; Elsner, P; Girolomoni, G; Herouy, Y; Idzko, M; Mockenhaupt, M; Norgauer, J; Panther, E; Sorichter, S; Windisch, W | 1 |
| Cortés, D; Díaz-Cruz, A; Guinzberg, R; Piña, E; Riveros-Rosas, H; Villalobos-Molina, R | 1 |
| Cheng, JJ; Huang, NK; Lai, WL; Lin, YR; Lu, MK | 1 |
| Bae, S; Lakshman, MK | 2 |
| Coe, IR; Naydenova, Z; Rose, JB | 1 |
| John, SA; Revin, SB | 1 |
| Kokatla, HP; Lakshman, MK | 1 |
| Andrei, G; Balachandran, R; Balzarini, J; Day, BW; Kumar, A; Lakshman, MK; Snoeck, R | 1 |
| Adam, RM; Chung, YG; Cristofaro, V; Doyle, C; Lukianov, SN; Sack, BS; Schäfer, M; Sullivan, MP | 1 |
| Beesley, J; Gause, WC; Haskó, G; Lovászi, M; Németh, ZH; Pacher, P | 1 |
13 other study(ies) available for triazoles and inosine
| Article | Year |
|---|---|
Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.
Topics: Guanazole; Inosine; Isoquinolines; Kinetics; Pyrazoles; Ribonucleotide Reductases; Simplexvirus; Triazoles | 1985 |
Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.
Topics: Alkaline Phosphatase; Amides; Animals; Antiviral Agents; Carcinoma, Ehrlich Tumor; Cell Line; Escherichia coli; Glycosides; Guanosine; Haplorhini; Inosine; Ketone Oxidoreductases; Kidney; Liver; Measles virus; Mice; Nucleosides; Nucleotides; Ribonucleosides; Triazoles; Tritium | 1973 |
Inosine stimulates chemotaxis, Ca2+-transients and actin polymerization in immature human dendritic cells via a pertussis toxin-sensitive mechanism independent of adenosine receptors.
Topics: Actins; Antigens, CD; Caffeine; Calcium; Cell Differentiation; Chemotaxis; Cytokines; Dendritic Cells; Dose-Response Relationship, Drug; Flow Cytometry; Histocompatibility Antigens Class I; Humans; Inosine; Pertussis Toxin; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Triazoles; Xanthines | 2004 |
Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors.
Topics: Adenosine; Adenosine A3 Receptor Antagonists; Animals; Calcium; Cell Hypoxia; Cyclic AMP; Gluconeogenesis; Glucose; Glycogen Phosphorylase; Glycogenolysis; Hepatocytes; Inosine; Liver; Male; Phylogeny; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Receptor, Adenosine A3; Receptors, G-Protein-Coupled; Receptors, Purinergic; Receptors, Purinergic P1; Triazoles; Urea | 2006 |
Adenosine as an active component of Antrodia cinnamomea that prevents rat PC12 cells from serum deprivation-induced apoptosis through the activation of adenosine A(2A) receptors.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Aminohydrolases; Animals; Apoptosis; Culture Media, Serum-Free; Inosine; PC12 Cells; Polyporales; Rats; Triazines; Triazoles | 2006 |
O6-(benzotriazol-1-yl)inosine derivatives: easily synthesized, reactive nucleosides.
Topics: DNA; Inosine; Magnetic Resonance Spectroscopy; Nucleosides; Organophosphorus Compounds; Triazoles | 2007 |
Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Animals; Cell Hypoxia; Cell Line; Cell Survival; Equilibrative Nucleoside Transporter 1; Equilibrative-Nucleoside Transporter 2; Inosine; Mice; Myocytes, Cardiac; Nucleoside Transport Proteins; Quinazolines; Receptor, Adenosine A1; Receptor, Adenosine A3; Thioinosine; Triazoles; Up-Regulation; Xanthines | 2008 |
A novel polymer supported approach to nucleoside modification.
Topics: Inosine; Magnetic Resonance Spectroscopy; Molecular Conformation; Nucleosides; Polymers; Stereoisomerism; Triazoles | 2008 |
Selective determination of inosine in the presence of uric acid and hypoxanthine using modified electrode.
Topics: Biosensing Techniques; Electrochemical Techniques; Electrodes; Humans; Hydrogen-Ion Concentration; Hypoxanthine; Inosine; Microscopy, Atomic Force; Oxidation-Reduction; Triazoles; Uric Acid | 2012 |
Two-step, one-pot synthesis of inosine, guanosine, and 2'-deoxyguanosine O6-ethers via intermediate O6-(benzotriazol-1-yl) derivatives.
Topics: Carbonates; Cesium; Deoxyguanosine; Ethers; Guanosine; Inosine; Organophosphorus Compounds; Triazoles | 2012 |
Synthesis and biological properties of C-2 triazolylinosine derivatives.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Proliferation; DNA Viruses; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Inosine; Mice; Microbial Sensitivity Tests; Molecular Structure; RNA Viruses; Stereoisomerism; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2012 |
Inosine attenuates spontaneous activity in the rat neurogenic bladder through an A
Topics: Adenosine A2 Receptor Antagonists; Animals; Disease Models, Animal; Humans; Inosine; Potassium Channels; Rats; Receptor, Adenosine A2A; Spinal Cord Injuries; Sulfonamides; Triazines; Triazoles; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Xanthines | 2017 |
Inosine monophosphate and inosine differentially regulate endotoxemia and bacterial sepsis.
Topics: Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Animals; Disease Models, Animal; Endotoxemia; Inosine; Inosine Monophosphate; Interleukin-10; Male; Mice; Mice, Inbred C57BL; Pneumonia, Pneumococcal; Quinazolines; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptor, Adenosine A3; Signal Transduction; Streptococcus pneumoniae; Triazoles; Tumor Necrosis Factor-alpha | 2021 |